Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Quoted Market Access Reimbursement

QUOTED. March 19, 2018. Michael Suk.

  • News

Executive Summary

Check out what Geisinger orthopedic surgeon Michael Suk had to say about the organization’s new partnership with hip-device firm Medacta International.

"When it comes to the hip replacement pilot program, we're saying to our patients that the level of service is so exemplary, that if there's a problem tomorrow or 20, 30 or 40 years from now, we'll take care of it." –Michael Suk, chair, Geisinger Musculoskeletal Institute

Find out more: Geisinger And Medacta Pilot Guarantees Coverage Of Hip Replacements For Life

Click here for a free trial of Medtech Insight

Table

View full table

Topics

Tags:
Quoted Market Access Reimbursement
Latest Headlines

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win

See All
UsernamePublicRestriction

Register

MT122331

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By